DFTX Definium Therapeutics, Inc.

NASDAQ
$30.16

Definium Therapeutics, Inc. (DFTX) Earnings News

Earnings press releases, previews and reviews for Definium Therapeutics, Inc. (DFTX), newest first. Our most recent is review: Definium Beats on a Warrant-Aided Loss as Two More Phase 3 Wins De-Risk DT120, but the Stock Still Sits Near Its Quarter Lows.